• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测Ⅰ期胃癌术后10年复发的列线图

Nomogram for predicting 10-year postoperative recurrence of stage I gastric cancer.

作者信息

Lyu Tong-Dan, Luo Ming-Peng, Hu Hao-Wei

机构信息

Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

Transl Cancer Res. 2024 Oct 31;13(10):5497-5508. doi: 10.21037/tcr-24-692. Epub 2024 Oct 28.

DOI:10.21037/tcr-24-692
PMID:39525020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11543093/
Abstract

BACKGROUND

With the advancement of various auxiliary examination techniques, the detection rate of stage I gastric cancer has gradually increased, and its clinical first-choice treatment is surgery. Although patients with stage I gastric cancer generally have a good postoperative survival rate, there is still a certain probability of recurrence. Given the large number of gastric cancer cases, there is a vast population of patients with stage I disease. We are aiming to identify the risk factors for postoperative recurrence of stage I gastric cancer and to establish a reliable predictive model to assess the risk of recurrence in the population for clinical practice.

METHODS

In this retrospective cohort study, we utilized the Surveillance, Epidemiology, and End Results (SEER) database to investigate predictive factors for recurrence among stage I gastric cancer patients who underwent curative gastrectomy between 2000 and 2018. The cohort was divided into training and validation sets for the development and validation of a nomogram. Prognostic factors were evaluated through univariate and multivariate Cox regression analyses. Significant variables identified by the concordance index (C-index) and calibration plots were used to construct nomograms predicting the probability of 5- and 10-year recurrence.

RESULTS

Risk factors for recurrence included sex, age, race, histology, tumor size, American Joint Committee on Cancer Tumor (AJCC T) and primary site, which were used to construct the nomogram. The C-index for both the training and validation cohorts indicated that the nomogram possessed good calibration and discrimination abilities in predicting the probability of 5- and 10-year recurrence after curative surgery for stage I gastric cancer.

CONCLUSIONS

This study established a reliable predictive model for recurrence following curative gastrectomy in stage I gastric cancer based on a population cohort. The findings of this study have the potential to significantly impact clinical practice by providing clinicians with tools for personalized risk assessment and for making informed treatment decisions.

摘要

背景

随着各种辅助检查技术的进步,I期胃癌的检出率逐渐提高,其临床首选治疗方法是手术。尽管I期胃癌患者术后生存率通常较好,但仍有一定的复发概率。鉴于胃癌病例数量众多,I期疾病患者群体庞大。我们旨在确定I期胃癌术后复发的危险因素,并建立一个可靠的预测模型,以评估该人群的复发风险,供临床实践使用。

方法

在这项回顾性队列研究中,我们利用监测、流行病学和最终结果(SEER)数据库,调查2000年至2018年间接受根治性胃切除术的I期胃癌患者的复发预测因素。该队列被分为训练集和验证集,用于开发和验证列线图。通过单因素和多因素Cox回归分析评估预后因素。通过一致性指数(C-index)和校准图确定的显著变量用于构建预测5年和10年复发概率的列线图。

结果

复发的危险因素包括性别、年龄、种族、组织学类型、肿瘤大小、美国癌症联合委员会肿瘤(AJCC T)和原发部位,这些因素被用于构建列线图。训练队列和验证队列的C-index均表明,该列线图在预测I期胃癌根治性手术后5年和10年复发概率方面具有良好的校准和区分能力。

结论

本研究基于人群队列建立了一个可靠的I期胃癌根治性胃切除术后复发预测模型。本研究结果有可能通过为临床医生提供个性化风险评估工具和做出明智治疗决策的工具,对临床实践产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/bd7b998aafe6/tcr-13-10-5497-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/21ed2a3074f2/tcr-13-10-5497-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/797727e9cb0f/tcr-13-10-5497-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/bd7b998aafe6/tcr-13-10-5497-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/21ed2a3074f2/tcr-13-10-5497-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/797727e9cb0f/tcr-13-10-5497-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebb/11543093/bd7b998aafe6/tcr-13-10-5497-f3.jpg

相似文献

1
Nomogram for predicting 10-year postoperative recurrence of stage I gastric cancer.预测Ⅰ期胃癌术后10年复发的列线图
Transl Cancer Res. 2024 Oct 31;13(10):5497-5508. doi: 10.21037/tcr-24-692. Epub 2024 Oct 28.
2
Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.基于 SEER 数据库分析建立低分化甲状腺癌患者癌症特异性生存的列线图模型并验证
Front Endocrinol (Lausanne). 2022 Sep 13;13:882279. doi: 10.3389/fendo.2022.882279. eCollection 2022.
3
Development and external validation of a nomogram predicting overall survival for Gastric adenocarcinoma patients with radical gastrectomy.基于根治性胃切除术的胃腺癌患者总生存预测列线图的建立与外部验证。
Scand J Gastroenterol. 2024 Jan-Jun;59(1):52-61. doi: 10.1080/00365521.2023.2250497. Epub 2023 Aug 26.
4
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
5
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.
6
A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.纳入治疗数据的列线图预测胃肠胰神经内分泌肿瘤患者的总生存:一项基于人群的队列研究。
Int J Surg. 2024 Apr 1;110(4):2178-2186. doi: 10.1097/JS9.0000000000001080.
7
Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.基于 SEER 数据库的回顾性研究:建立预测舌底鳞癌患者癌症特异性生存的预后列线图。
Cancer Control. 2023 Jan-Dec;30:10732748231210733. doi: 10.1177/10732748231210733.
8
A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation.一种基于 SEER 数据库的新型列线图和风险分层系统预测胃神经内分泌癌患者的癌症特异性生存:一项外部验证研究。
BMC Gastroenterol. 2023 Jul 14;23(1):238. doi: 10.1186/s12876-023-02875-4.
9
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
10
Development and validation of a prognostic model to predict the prognosis of patients with colorectal gastrointestinal stromal tumor: A large international population-based cohort study.预测结直肠胃肠道间质瘤患者预后的预后模型的开发与验证:一项基于国际大人群的队列研究。
Front Oncol. 2022 Nov 2;12:1004662. doi: 10.3389/fonc.2022.1004662. eCollection 2022.

本文引用的文献

1
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.血清 NY-ESO-1 抗体作为胃癌术后复发的预测性生物标志物:一项多中心前瞻性观察研究。
Br J Cancer. 2024 Apr;130(7):1157-1165. doi: 10.1038/s41416-023-02540-3. Epub 2024 Feb 7.
2
Robustly federated learning model for identifying high-risk patients with postoperative gastric cancer recurrence.用于识别胃癌术后复发高危患者的稳健联邦学习模型。
Nat Commun. 2024 Jan 25;15(1):742. doi: 10.1038/s41467-024-44946-4.
3
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer.
辅助化疗后残留循环肿瘤 DNA 能有效预测 II-III 期胃癌的复发。
Cancer Commun (Lond). 2023 Dec;43(12):1312-1325. doi: 10.1002/cac2.12494. Epub 2023 Oct 14.
4
A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.一种用于预测胃癌患者早期复发的液体活检标志物。
Br J Cancer. 2023 Apr;128(6):1105-1116. doi: 10.1038/s41416-022-02138-1. Epub 2023 Jan 11.
5
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.利用多任务深度学习从胃癌CT图像预测腹膜复发和无病生存期:一项回顾性研究
Lancet Digit Health. 2022 May;4(5):e340-e350. doi: 10.1016/S2589-7500(22)00040-1.
6
Epidemiology of stomach cancer.胃癌流行病学
World J Gastroenterol. 2022 Mar 28;28(12):1187-1203. doi: 10.3748/wjg.v28.i12.1187.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence.胃癌组织的代谢组学分析确定了预测腹膜复发的潜在生物标志物。
Gastric Cancer. 2020 Sep;23(5):874-883. doi: 10.1007/s10120-020-01065-5. Epub 2020 Mar 26.
9
Recent advances in gastric cancer early diagnosis.胃癌早期诊断的最新进展。
World J Gastroenterol. 2019 May 7;25(17):2029-2044. doi: 10.3748/wjg.v25.i17.2029.
10
Superiority of the 8th edition of the TNM staging system for predicting overall survival in gastric cancer: Comparative analysis of the 7th and 8th editions in a monoinstitutional cohort.第8版TNM分期系统在预测胃癌总生存期方面的优越性:单中心队列中第7版与第8版的比较分析
Mol Clin Oncol. 2018 Oct;9(4):423-431. doi: 10.3892/mco.2018.1683. Epub 2018 Jul 26.